Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2012, Vol. 32 Issue (03): 25-31    DOI:
    
Analysis of the Bacterial Community in Gastric Samples from Mice with TypeⅡDiabetes by Using PCR-DGGE Fingerprint
DU Cai-he1, HU Fang2, WEI Ting-ting1, ZHANG Ren-min1, ZHANG Hong-lin2, ZHOU Dong-rui1, LU Zu-hong1,2
1. Research Center for Learning Science, Southeast University, Nanjing 210096, China;
2. School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China
Download: HTML   PDF(663KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Gastrointestinal complications are common in patients with diabetes mellitus which involve the acute gastritis and gastric ulcer. Because gastric dyskinesis, delayed gastric emptying, gastric bacterial over-growth, these will further lead to intestinal diseases. Research on the change in diabetes stomach content bacterium group structure, and it’is important for the study of diabetes pathogenesis and the treatment of complications. Bacterial DNAs from 10 type 2 diabetes mice and 10 normal control mice were extracted from gastric contents and gastric mucosal samples and then characterized by PCR-denaturing gradient gel electrophoresis (DGGE). After DGGE profilings was obtained,the diversity and similarity analyses were carried out by the number of band,Shannon-Weaver(H’), Margalef index(R), Pielou index(E) and Simpson index(D),cluster analysis and cloning sequencing. The results show that there was no significant difference in Shannon-Weaver diversity index、Margalef index 、Pielou index、and Simpson index between experimental group and control group. There is no significant distinction in the Dice similarity coefficient (Cs) between the two groups. The result of sequencing illustrates that Lactobacillus is in the gastric of normal control mice, but type 2 diabetes mice. These results suggest that lactobacillus is closely related to type 2 diabetes.



Key wordsType 2 diabetes      Mice      Gastric flora      DGGE     
Received: 03 August 2011      Published: 25 March 2012
ZTFLH:  Q7  
Cite this article:

DU Cai-he, HU Fang, WEI Ting-ting, ZHANG Ren-min, ZHANG Hong-lin, ZHOU Dong-rui, LU Zu-hong. Analysis of the Bacterial Community in Gastric Samples from Mice with TypeⅡDiabetes by Using PCR-DGGE Fingerprint. China Biotechnology, 2012, 32(03): 25-31.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2012/V32/I03/25


[1] 胡善联,刘国恩,许樟荣,等. 我国糖尿病流行病学和疾病经济负担研究现状.中国卫生经济, 2008, 27(8):5-8. Hu S L, Liu G E, Xu Z R, et al. Current Status of Epidemic and Economic Burden of Diabetes Mellitus in China.Chinese Health Economics, 2008, 27(8):5-8.

[2] Boehme M W, Autschbach F, Ell C, et al. Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus-a cross-sectional study. Hepatogastroenterology, 2007, 54(74):643-648.

[3] 张天成. 糖尿病胃肠道并发症. 世界华人消化杂志, 2006, 14 (29):2868 - 2871. Zhang T C. Progress in gastrointestinal complications of diabetes.World Chinese Journal of Digestion, 2006, 14 (29):2868 - 2871.

[4] 蓝宇, 张贲, 叶华,等. 糖尿病消化不良症状调查及其与其他脏器合并症关系. 基础医学与临床, 2001, 21(增刊):81. Lan Y, Zhang B, Ye H, et al. Investigation of Dyspeptic Symptoms of Diabetes and Its Complications in Relations with Other Organs.Basic Medical Sciences and Clinics, 2001, 21(supplement):81.

[5] 纪小龙, 刘小兵. 胃肠道疾病的分子生物学基础.世界华人消化杂志, 1998, 6 (10):905-910. Ji X L, Liu X B. Gastrointestinal Diseases in Molecular Biology. World Chinese Journal of digestion, 1998, 6 (10):905-910.

[6] Gulcelik N E, Kaya E, Demirbas B, et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. Endocrinol Invest, 2005, 28(3):214-217.

[7] Patrice D C, Nathalie M D. Interplay between obesity and associated metabolic disorders:new insights into the gut microbiota. Current Opinion in Pharmacology, 2009, 9(6):737-743.

[8] Cani P D, Delzenne N M, Amar J, et al. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathologie Biologie, 2008, 56(5):305-309.

[9] Serino M, Luche E, Chabo C, et al. Intestinal microflora and metabolic diseases. Diabetes & Metabolism, 2009, 35(4):262-272.

[10] Muyzer G, Waal E C, Uitterlinden A G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Applied and Environmental Microbiology, 1993, 59(3):695-700.

[11] Thompson J R, Marcelino L A, Polz M F. Heteroduplexes in mixed-template amplifications:formation, consequence and elimination by 'reconditioning PCR’. Nucleic Acids Research, 2002, 30(9):2083-2088.

[12] 张 谦,杨文奇. 2型糖尿病患者幽门螺旋杆菌感染及其临床意义. 长春中医药大学学报, 2007,23(3):71. Zhang Q, Yang W Q. Helicobacter Pylori Infection in Type 2 Diabetes and Clinical Significance. Journal of Changchun University of Traditional Chinese Medicine, 2007, 23(3):71.

[13] 刘芬,王秀锋,黄沁. 幽门螺杆菌感染与糖尿病关系的研究进展. 中国医疗前沿,2010,5(14):10. Liu F, Wang X F, Huang Q. National Medical Frontiers of China, 2010,5(14):10.

[14] 孙光喜,谭悦菊, 祝永丽. 2型糖尿病与幽门螺杆菌感染. 实用医技杂志,2007,14(28):3868-3869. Sun G X, Tan Y J, Zhu Y L. The Relationship Between Type 2 Diabetes Mellitus and H Pylori Infection.Journal of Practical Medical Techniques,2007, 14(28):3868-3869.

[15] 严颂琴,谌剑飞,田贺暖.等. 2 型糖尿病患者与幽门螺杆菌感染的关系研究. 实用糖尿病杂志,2007,4(4):21-22. Yang S Q, Tan J F, Tian H N, et al. Research in The Relationship between Type 2 Diabetes and Helicobacter Pylori Infection. Journal of Practical Diabetology, 2007,4(4):21-22.

[16] 林辉, 任建林. 幽门螺杆菌与胃黏膜保护研究进展.世界华人消化杂志, 2005,13(21):2586-2590. Lin H, Ren J L. Advance in relationship between Helicobacter pylori and gastric mucosal protection. World Chinese Journal of Digestion, 2005, 13(21):2586-2590.

[17] Jadoon N A, Shahzad M A, Yaqoob R, et al. Seroprevalence of hepatitis C in type 2 diabetes:evidence for a positive association. Virology Journal, 2010, 7(1):304.

[18] Goldin E, Ardite E, Elizalde J I, et al. Gastric mucosal damage in experimental diabetes in rats:role of endogenous glutathione. Gastroenterology, 1997, 112(3):855-863.

[19] 徐灵筠.1型糖尿病鼠类模型的肠道菌群分析. 上海:上海交通大学, 生命科学技术学院,2007. Xu L J. Intestinal Microflora Analysis for Type 1 Diabetic Murine. Shanghai:Shanghai Jiao Tong University, School of Life Science and Biotechnology, 2007.

[20] Yadav H, Jain S, Sinha P R,et al. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. Journal of Dairy Research, 2008, 75(2):189-195.

[21] Yun S I, Park H O, Kang J H, et al. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. Journal of Applied Microbiology 2009, 107(5):1681-1686.

[1] Chao-jing GUO,Qiong ZHU,Xin ZHANG,Lei LI,Ling-qiang ZHANG. Generation and Phenotypic Analysis of Hepatic-specific Deubiquitinase OTUB1 Knockout Mice Model[J]. China Biotechnology, 2019, 39(5): 80-87.
[2] Hong-miao DAI,Ye-sheng FU,Ling-qiang ZHANG. Construction of YOD1 Knockout Mice on CRISPR/Cas9 Technology[J]. China Biotechnology, 2018, 38(6): 52-57.
[3] WANG De-hua, MA Yi, HAN Lei, XIAO Xing, LI Yan-wei, DANG Shi-ying, FAN Zhi-yong, WEN Tao, HONG An. Preparation of Novel Recombinant PACAP Derivative MPL-2 and Its Effect on Anti-type 2 Diabetes Mellitus[J]. China Biotechnology, 2017, 37(5): 59-65.
[4] ZHOU Zhong-ting, ZHANG Quan, WANG Sheng-tao, CAI Yin, NAKANISHI Hideki, YIN Jian. Polymeric Nanomicelles Conjugated with BODIPY-based Photosensitizers for Targeted Photodynamic Therapy[J]. China Biotechnology, 2017, 37(10): 33-41.
[5] GE Lin, LIU Xin-yu, WANG Guirong. Construction of Human SP-B Protein Transgenic Mice and Bacterial Pneumonia Model[J]. China Biotechnology, 2017, 37(10): 65-71.
[6] ZUO Zhi-yu, XIN Ling-biao, YANG Jie, WANG Xin-ting. Construction of SND1 Transgenic Mice[J]. China Biotechnology, 2016, 36(4): 97-103.
[7] YI Xue-rui, YUAN You-cheng, GONG Liang, ZHANG Xin-rui, LI Na, KONG Xiang-ping. The Inhibition of HBsAg of Natural Compounds and Bortezomib on Primary Hepatocytes of HBV-Tg Mice and the Proteome Analysis[J]. China Biotechnology, 2015, 35(11): 29-35.
[8] CONG Shan, WANG Xiu-mei, LI Yan, SONG Jing, BAI Li-heng, CAO Gui-fang. Human Amnion Mesenchymal Stem Cells Positioned Transplantation for the Treatment of Mice Liver Damage Induced by Carbon Tetrachloride[J]. China Biotechnology, 2014, 34(8): 14-23.
[9] QIN Yao, ZHAO Hong-yan, ZHANG Wen-hang, WANG Dong-mei. Generation of Mitochondrial Transcription Factor a Knockdown Transgenic Mice[J]. China Biotechnology, 2014, 34(7): 44-48.
[10] HUANG Xiang-feng, ZHAN Peng-ju, PENG Kai-ming, LIU Jia, LU Li-jun. Study on the Influence of Iron Dosage in the Medium on Fermentation of Lipopeptide Produced by Bacillus subtilis CICC 23659[J]. China Biotechnology, 2013, 33(6): 52-61.
[11] WANG Yan-ling, FANG Jing, ZHANG Tian-zuo, LI Hao, LI Fei-fei, TAO Ming-zhen, WANG Xiao-hua, MAO Jian-ping. The Preliminary Anti-radiation Study on C57 Mice Irradiated by 8Gy γ Ray After Gavaged Acai Based Herbal Supplementary Blend and Noni Fruit Powder[J]. China Biotechnology, 2012, 32(04): 33-40.
[12] JIANG Shi-zhong, YAN Ya-bin, XIE Fei, GONG Xiu-li, HUANG Ying, LV Bao-zhong. The Primary Cell Culture of Human Transferrin Transgenic Mouse Mammary Epithelia and the Study of the Cells Reponse to Bovine Prolactin[J]. China Biotechnology, 2012, 32(03): 20-24.
[13] LIU Yan-jie, JI Hong, LIN Lu-xia, ZANG Xue-zhang, SONG Chang-zheng, RONG Hai-qin. Solid Phase Peptide Synthesis and Analysis for Exendin-4[J]. China Biotechnology, 2011, 31(02): 69-73.
[14] GUO Gong-Min, TUN Xiao-Ji, LI Xiang, ZHOU Yan-Rong, LIN Yan-Li, XIONG Fu-Yin, XUE Shi-Wei, CHEN Gong-Xing, CHEN Shu-Lin. Establishment of the Transgenic Mice Expressing the HBV Receptor Human ASGPR[J]. China Biotechnology, 2010, 30(05): 87-91.
[15] . Purification of Kallikrein Using Reverse Micellar Extraction[J]. China Biotechnology, 2007, 27(3): 93-99.